MedRhythms

Website

MedRhythms, Inc.

3 Investors
Digital Therapeutics
PORTLAND, ME

MedRhythms, Inc. is a pioneering digital therapeutics company dedicated to transforming healthcare for individuals suffering from neurologic injuries and diseases. By harnessing the intricate link between music and neuroscience, the company focuses on developing innovative therapeutic solutions aimed at addressing mobility challenges and enhancing functional outcomes for affected individuals.

Products & Team

Digital Therapeutic Platform

Rehabilitation TechnologySeed

MedRhythms' flagship product is a sophisticated digital therapeutic platform that utilizes patented technology combining music, sensors, and software. It employs the principle of Rhythmic Auditory Stimulation (RAS) to deliver clinically validated treatments that significantly improve walking impairments by retraining motor functions through rhythm-based neural stimulation.

Value Proposition

This platform addresses severe mobility issues resulting from neurologic conditions, helping patients regain independence and improve their quality of life.

Pain Points

The main customer problems addressed include reduced mobility, dependency on caregivers, diminished quality of life, and increasing healthcare costs associated with chronic walking disabilities.

Integration of wearable sensors to monitor patient progressAdaptive algorithms for personalized therapyClinical research-backed efficacyUtilization of personalized music through partnership with Universal Music Group
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
PORTLAND, ME
Primary headquarters

Funding History

Total Raised:
$2.9M
E

Debt Financing, Option to Acquire Offering

March 2025
$8.0M
Target
Progress
36%
Raised
$2.9M
Target
$8.0M
#000174612525000002